Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Pharmathen SA

02 3Key Oncologics

03 3Novartis South Africa (Pty) Ltd

04 8Recordati

05 15Recordati Rare Diseases

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : USA

Registration Country : Greece

Pasireotide

Brand Name :

Dosage Form : Long Acting Injectable

Dosage Strength : 20MG/VIAL

Packaging :

Approval Date :

Application Number :

Regulatory Info : USA

Registration Country : Greece

Pharmathen

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : USA

Registration Country : Greece

Pasireotide

Brand Name :

Dosage Form : Long Acting Injectable

Dosage Strength : 40MG/VIAL

Packaging :

Approval Date :

Application Number :

Regulatory Info : USA

Registration Country : Greece

Pharmathen

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : USA

Registration Country : Greece

Pasireotide

Brand Name :

Dosage Form : Long Acting Injectable

Dosage Strength : 60MG/VIAL

Packaging :

Approval Date :

Application Number :

Regulatory Info : USA

Registration Country : Greece

Pharmathen

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotide

Brand Name : SIGNIFOR LA 20 mg

Dosage Form : INJ

Dosage Strength : 20mg/2ml

Packaging : 2X1mg/2ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Sparrow

Brand Name : Signifor

Dosage Form : Solution For Injection

Dosage Strength : 0.3mg/ml

Packaging :

Approval Date : 02/11/2012

Application Number : 61254

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Sparrow

Brand Name : Signifor

Dosage Form : Solution For Injection

Dosage Strength : 0.6mg/ml

Packaging :

Approval Date : 02/11/2012

Application Number : 61254

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Sparrow

Brand Name : Signifor

Dosage Form : Solution For Injection

Dosage Strength : 0.9mg/ml

Packaging :

Approval Date : 02/11/2012

Application Number : 61254

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Sparrow

Brand Name : Signifor LAR

Dosage Form : Solution For Injection

Dosage Strength : 20mg/2ml

Packaging :

Approval Date : 25/02/2015

Application Number : 65148

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Sparrow

Brand Name : Signifor LAR

Dosage Form : Solution For Injection

Dosage Strength : 40mg/2ml

Packaging :

Approval Date : 25/02/2015

Application Number : 65148

Regulatory Info : Allowed

Registration Country : Switzerland

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Sparrow

Brand Name : Signifor LAR

Dosage Form : Solution For Injection

Dosage Strength : 60mg/2ml

Packaging :

Approval Date : 25/02/2015

Application Number : 65148

Regulatory Info : Allowed

Registration Country : Switzerland

blank

11

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Sparrow

Brand Name : Signifor LAR powder and solution for suspension for injection

Dosage Form : Solution For Injection

Dosage Strength : 10mg/2ml

Packaging :

Approval Date : 25/02/2015

Application Number : 65148

Regulatory Info : Allowed

Registration Country : Switzerland

blank

12

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Sparrow

Brand Name : Signifor LAR

Dosage Form : Solution For Injection

Dosage Strength : 30mg/2ml

Packaging :

Approval Date : 25/02/2015

Application Number : 65148

Regulatory Info : Allowed

Registration Country : Switzerland

blank

13

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotide Diaspartate

Brand Name : Significance

Dosage Form : Injectable Solution

Dosage Strength : 0.3mg

Packaging :

Approval Date : 24/04/2012

Application Number : 20101005000034

Regulatory Info : Approved

Registration Country : Sweden

blank

14

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotide Diaspartate

Brand Name : Significance

Dosage Form : Injectable Solution

Dosage Strength : 0.6mg

Packaging :

Approval Date : 24/04/2012

Application Number : 20101005000041

Regulatory Info : Approved

Registration Country : Sweden

blank

15

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotide Diaspartate

Brand Name : Significance

Dosage Form : Injectable Solution

Dosage Strength : 0.9mg

Packaging :

Approval Date : 24/04/2012

Application Number : 20101005000058

Regulatory Info : Approved

Registration Country : Sweden

blank

16

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotidembonate

Brand Name : Significance

Dosage Form : Powder For Injection

Dosage Strength : 10mg

Packaging :

Approval Date : 18/09/2017

Application Number : 20161202000022

Regulatory Info : Approved

Registration Country : Sweden

blank

17

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotidembonate

Brand Name : Significance

Dosage Form : Powder For Injection

Dosage Strength : 20mg

Packaging :

Approval Date : 19/11/2014

Application Number : 20131101000010

Regulatory Info : Approved

Registration Country : Sweden

blank

18

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotidembonate

Brand Name : Significance

Dosage Form : Powder For Injection

Dosage Strength : 30mg

Packaging :

Approval Date : 18/09/2017

Application Number : 20161202000039

Regulatory Info : Approved

Registration Country : Sweden

blank

19

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotidembonate

Brand Name : Significance

Dosage Form : Powder For Injection

Dosage Strength : 40mg

Packaging :

Approval Date : 19/11/2014

Application Number : 20131101000027

Regulatory Info : Approved

Registration Country : Sweden

blank

20

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotidembonate

Brand Name : Significance

Dosage Form : Powder For Injection

Dosage Strength : 60mg

Packaging :

Approval Date : 19/11/2014

Application Number : 20131101000034

Regulatory Info : Approved

Registration Country : Sweden

blank